Tunisia

Tunisia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.42 (2.19 - 2.66) 2019 Modelled IHME
2.42 (2.20 - 2.64) 2018 Modelled IHME
2.42 (2.18 - 2.64) 2017 Modelled IHME
2.42 (2.20 - 2.63) 2016 Modelled IHME
2.42 (2.22 - 2.64) 2015 Modelled IHME
2.45 (2.26 - 2.66) 2014 Modelled IHME
2.5 (2.32 - 2.71) 2013 Modelled IHME
2.58 (2.38 - 2.80) 2012 Modelled IHME
2.66 (2.42 - 2.90) 2011 Modelled IHME
2.73 (2.49 - 2.98) 2010 Modelled IHME
2.8 (2.55 - 3.05) 2009 Modelled IHME
2.87 (2.61 - 3.12) 2008 Modelled IHME
2.94 (2.67 - 3.20) 2007 Modelled IHME
3.01 (2.72 - 3.29) 2006 Modelled IHME
3.09 (2.78 - 3.38) 2005 Modelled IHME
3.17 (2.86 - 3.46) 2004 Modelled IHME
3.26 (2.94 - 3.54) 2003 Modelled IHME
3.35 (3.03 - 3.64) 2002 Modelled IHME
3.45 (3.11 - 3.76) 2001 Modelled IHME
3.56 (3.20 - 3.89) 2000 Modelled IHME
3.68 (3.31 - 4.02) 1999 Modelled IHME
3.81 (3.43 - 4.17) 1998 Modelled IHME
3.95 (3.55 - 4.33) 1997 Modelled IHME
4.09 (3.67 - 4.49) 1996 Modelled IHME
4.21 (3.78 - 4.64) 1995 Modelled IHME
4.32 (3.89 - 4.75) 1994 Modelled IHME
4.43 (3.99 - 4.84) 1993 Modelled IHME
4.53 (4.10 - 4.96) 1992 Modelled IHME
4.62 (4.20 - 5.04) 1991 Modelled IHME
4.7 (4.29 - 5.15) 1990 Modelled IHME
4.91 (4.01 - 6.15) 2015 Modelled WHO
3.9 (3.60 - 4.20) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.27 (0.22 - 0.33) 2019 Modelled IHME
0.28 (0.23 - 0.34) 2018 Modelled IHME
0.29 (0.24 - 0.35) 2017 Modelled IHME
0.3 (0.25 - 0.36) 2016 Modelled IHME
0.31 (0.26 - 0.37) 2015 Modelled IHME
0.31 (0.26 - 0.37) 2014 Modelled IHME
0.32 (0.27 - 0.38) 2013 Modelled IHME
0.32 (0.27 - 0.38) 2012 Modelled IHME
0.32 (0.27 - 0.38) 2011 Modelled IHME
0.33 (0.27 - 0.39) 2010 Modelled IHME
0.32 (0.27 - 0.38) 2009 Modelled IHME
0.32 (0.26 - 0.37) 2008 Modelled IHME
0.31 (0.26 - 0.37) 2007 Modelled IHME
0.3 (0.25 - 0.36) 2006 Modelled IHME
0.3 (0.24 - 0.36) 2005 Modelled IHME
0.32 (0.26 - 0.38) 2004 Modelled IHME
0.35 (0.29 - 0.42) 2003 Modelled IHME
0.41 (0.33 - 0.48) 2002 Modelled IHME
0.47 (0.38 - 0.55) 2001 Modelled IHME
0.52 (0.42 - 0.62) 2000 Modelled IHME
0.56 (0.46 - 0.66) 1999 Modelled IHME
0.6 (0.49 - 0.70) 1998 Modelled IHME
0.64 (0.53 - 0.75) 1997 Modelled IHME
0.69 (0.58 - 0.81) 1996 Modelled IHME
0.77 (0.64 - 0.90) 1995 Modelled IHME
0.99 (0.83 - 1.17) 1994 Modelled IHME
1.44 (1.21 - 1.69) 1993 Modelled IHME
2.05 (1.73 - 2.41) 1992 Modelled IHME
2.79 (2.33 - 3.30) 1991 Modelled IHME
3.6 (2.97 - 4.30) 1990 Modelled IHME
0.76 (0.51 - 1.08) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
397,042 (361,707 - 434,608) 1990 Modelled IHME
398,170 (362,076 - 434,627) 1991 Modelled IHME
398,165 (360,922 - 436,010) 1992 Modelled IHME
396,983 (357,401 - 434,215) 1993 Modelled IHME
394,586 (355,224 - 433,445) 1994 Modelled IHME
390,922 (350,428 - 430,570) 1995 Modelled IHME
385,307 (345,449 - 422,803) 1996 Modelled IHME
377,638 (338,847 - 413,402) 1997 Modelled IHME
368,866 (331,832 - 402,967) 1998 Modelled IHME
360,012 (324,327 - 393,442) 1999 Modelled IHME
352,128 (316,732 - 384,857) 2000 Modelled IHME
345,220 (311,407 - 376,263) 2001 Modelled IHME
338,597 (306,040 - 367,625) 2002 Modelled IHME
332,258 (300,163 - 361,137) 2003 Modelled IHME
326,212 (294,811 - 356,075) 2004 Modelled IHME
320,461 (289,041 - 351,003) 2005 Modelled IHME
315,061 (285,256 - 344,324) 2006 Modelled IHME
310,009 (281,773 - 337,969) 2007 Modelled IHME
305,200 (278,111 - 332,334) 2008 Modelled IHME
300,513 (273,869 - 327,510) 2009 Modelled IHME
295,818 (268,952 - 322,776) 2010 Modelled IHME
290,155 (264,492 - 316,077) 2011 Modelled IHME
283,587 (261,510 - 308,044) 2012 Modelled IHME
277,536 (256,931 - 300,918) 2013 Modelled IHME
273,457 (252,561 - 297,117) 2014 Modelled IHME
272,854 (249,545 - 296,775) 2015 Modelled IHME
274,686 (250,002 - 298,418) 2016 Modelled IHME
276,612 (249,233 - 301,891) 2017 Modelled IHME
278,356 (252,447 - 303,726) 2018 Modelled IHME
279,983 (253,015 - 307,292) 2019 Modelled IHME
444,000 (414,000 - 477,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.83 (1.23 - 2.70) 2019 Modelled IHME
1.83 (1.22 - 2.72) 2018 Modelled IHME
1.82 (1.20 - 2.72) 2017 Modelled IHME
1.8 (1.18 - 2.66) 2016 Modelled IHME
1.78 (1.18 - 2.60) 2015 Modelled IHME
1.77 (1.16 - 2.61) 2014 Modelled IHME
1.76 (1.16 - 2.54) 2013 Modelled IHME
1.75 (1.17 - 2.55) 2012 Modelled IHME
1.74 (1.16 - 2.52) 2011 Modelled IHME
1.72 (1.13 - 2.48) 2010 Modelled IHME
1.7 (1.12 - 2.43) 2009 Modelled IHME
1.68 (1.11 - 2.41) 2008 Modelled IHME
1.66 (1.11 - 2.36) 2007 Modelled IHME
1.64 (1.12 - 2.32) 2006 Modelled IHME
1.63 (1.11 - 2.30) 2005 Modelled IHME
1.67 (1.14 - 2.36) 2004 Modelled IHME
1.76 (1.19 - 2.43) 2003 Modelled IHME
1.87 (1.25 - 2.55) 2002 Modelled IHME
1.95 (1.32 - 2.67) 2001 Modelled IHME
1.98 (1.36 - 2.68) 2000 Modelled IHME
1.99 (1.38 - 2.64) 1999 Modelled IHME
1.99 (1.40 - 2.64) 1998 Modelled IHME
1.98 (1.39 - 2.64) 1997 Modelled IHME
1.96 (1.37 - 2.60) 1996 Modelled IHME
1.99 (1.38 - 2.62) 1995 Modelled IHME
2.01 (1.36 - 2.70) 1994 Modelled IHME
2.09 (1.38 - 2.85) 1993 Modelled IHME
2.17 (1.39 - 3.09) 1992 Modelled IHME
2.27 (1.39 - 3.42) 1991 Modelled IHME
2.39 (1.37 - 3.83) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
211 (143 - 313) 2019 Modelled IHME
210 (140 - 313) 2018 Modelled IHME
207 (137 - 311) 2017 Modelled IHME
204 (134 - 302) 2016 Modelled IHME
201 (132 - 292) 2015 Modelled IHME
198 (130 - 291) 2014 Modelled IHME
195 (128 - 282) 2013 Modelled IHME
192 (129 - 280) 2012 Modelled IHME
190 (127 - 275) 2011 Modelled IHME
186 (122 - 269) 2010 Modelled IHME
182 (120 - 261) 2009 Modelled IHME
179 (118 - 256) 2008 Modelled IHME
175 (117 - 249) 2007 Modelled IHME
172 (117 - 243) 2006 Modelled IHME
170 (115 - 239) 2005 Modelled IHME
172 (117 - 243) 2004 Modelled IHME
180 (121 - 247) 2003 Modelled IHME
189 (127 - 258) 2002 Modelled IHME
195 (132 - 267) 2001 Modelled IHME
196 (135 - 265) 2000 Modelled IHME
195 (135 - 259) 1999 Modelled IHME
193 (135 - 255) 1998 Modelled IHME
189 (133 - 252) 1997 Modelled IHME
185 (130 - 245) 1996 Modelled IHME
185 (128 - 244) 1995 Modelled IHME
184 (124 - 246) 1994 Modelled IHME
188 (124 - 256) 1993 Modelled IHME
191 (123 - 272) 1992 Modelled IHME
196 (120 - 295) 1991 Modelled IHME
202 (116 - 323) 1990 Modelled IHME
274 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
28 (20 - 37) 2019 Modelled IHME
28 (21 - 37) 2018 Modelled IHME
28 (21 - 38) 2017 Modelled IHME
28 (21 - 37) 2016 Modelled IHME
28 (21 - 37) 2015 Modelled IHME
28 (21 - 37) 2014 Modelled IHME
28 (21 - 37) 2013 Modelled IHME
28 (21 - 37) 2012 Modelled IHME
28 (21 - 37) 2011 Modelled IHME
28 (21 - 37) 2010 Modelled IHME
28 (21 - 37) 2009 Modelled IHME
28 (21 - 37) 2008 Modelled IHME
28 (21 - 37) 2007 Modelled IHME
28 (21 - 37) 2006 Modelled IHME
28 (21 - 37) 2005 Modelled IHME
28 (21 - 38) 2004 Modelled IHME
29 (22 - 38) 2003 Modelled IHME
30 (22 - 39) 2002 Modelled IHME
30 (23 - 39) 2001 Modelled IHME
31 (23 - 40) 2000 Modelled IHME
31 (23 - 40) 1999 Modelled IHME
31 (23 - 40) 1998 Modelled IHME
31 (23 - 40) 1997 Modelled IHME
31 (23 - 40) 1996 Modelled IHME
31 (23 - 40) 1995 Modelled IHME
31 (23 - 41) 1994 Modelled IHME
31 (23 - 41) 1993 Modelled IHME
31 (23 - 41) 1992 Modelled IHME
32 (24 - 42) 1991 Modelled IHME
32 (24 - 42) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
81 2018 Survey/reported WHO/UNICEF
83 2017 Survey/reported WHO/UNICEF
85 2016 Survey/reported WHO/UNICEF
88 2015 Survey/reported WHO/UNICEF
80 2014 Survey/reported WHO/UNICEF
82 2013 Survey/reported WHO/UNICEF
73 2012 Survey/reported WHO/UNICEF
80 2011 Survey/reported WHO/UNICEF
82 2010 Survey/reported WHO/UNICEF
88 2009 Survey/reported WHO/UNICEF
92 2008 Survey/reported WHO/UNICEF
89 2007 Survey/reported WHO/UNICEF
74 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
98 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
97 2012 Survey/reported WHO/UNICEF
98 2011 Survey/reported WHO/UNICEF
98 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
98 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
97 2005 Survey/reported WHO/UNICEF
96 2004 Survey/reported WHO/UNICEF
92 2003 Survey/reported WHO/UNICEF
93 2002 Survey/reported WHO/UNICEF
94 2001 Survey/reported WHO/UNICEF
94 2000 Survey/reported WHO/UNICEF
94 1999 Survey/reported WHO/UNICEF
91 1998 Survey/reported WHO/UNICEF
88 1997 Survey/reported WHO/UNICEF
83 1996 Survey/reported WHO/UNICEF
92 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2014 Survey/reported Ministere de la Sante Publique, 2014.
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
2006
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.26 (1.03 - 1.54) 2019 Modelled IHME
1.24 (1.02 - 1.54) 2018 Modelled IHME
1.23 (1 - 1.53) 2017 Modelled IHME
1.2 (0.98 - 1.48) 2016 Modelled IHME
1.18 (0.96 - 1.44) 2015 Modelled IHME
1.17 (0.96 - 1.42) 2014 Modelled IHME
1.16 (0.95 - 1.40) 2013 Modelled IHME
1.15 (0.94 - 1.39) 2012 Modelled IHME
1.14 (0.93 - 1.38) 2011 Modelled IHME
1.13 (0.93 - 1.38) 2010 Modelled IHME
1.13 (0.92 - 1.37) 2009 Modelled IHME
1.12 (0.91 - 1.37) 2008 Modelled IHME
1.11 (0.91 - 1.36) 2007 Modelled IHME
1.11 (0.90 - 1.36) 2006 Modelled IHME
1.09 (0.89 - 1.35) 2005 Modelled IHME
1.05 (0.86 - 1.30) 2004 Modelled IHME
0.98 (0.80 - 1.20) 2003 Modelled IHME
0.9 (0.74 - 1.09) 2002 Modelled IHME
0.82 (0.67 - 0.99) 2001 Modelled IHME
0.76 (0.62 - 0.91) 2000 Modelled IHME
0.72 (0.59 - 0.86) 1999 Modelled IHME
0.68 (0.56 - 0.82) 1998 Modelled IHME
0.65 (0.54 - 0.78) 1997 Modelled IHME
0.63 (0.52 - 0.75) 1996 Modelled IHME
0.62 (0.51 - 0.74) 1995 Modelled IHME
0.63 (0.52 - 0.76) 1994 Modelled IHME
0.66 (0.55 - 0.79) 1993 Modelled IHME
0.7 (0.58 - 0.84) 1992 Modelled IHME
0.76 (0.63 - 0.91) 1991 Modelled IHME
0.83 (0.68 - 1) 1990 Modelled IHME
0.9 (0.20 - 1.10) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.3 (0.30 - 2.50) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
29.1 (25.70 - 32.60) 2009 Survey/reported Benzineb S and Hsairi M, 2009
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
69,865 (57,566 - 83,989) 1990 Modelled IHME
65,353 (54,002 - 78,352) 1991 Modelled IHME
61,665 (51,258 - 73,726) 1992 Modelled IHME
59,014 (48,926 - 70,636) 1993 Modelled IHME
57,621 (47,639 - 69,071) 1994 Modelled IHME
57,708 (47,530 - 69,119) 1995 Modelled IHME
59,339 (49,140 - 70,909) 1996 Modelled IHME
62,220 (51,664 - 74,368) 1997 Modelled IHME
66,034 (54,505 - 79,170) 1998 Modelled IHME
70,447 (57,877 - 84,616) 1999 Modelled IHME
75,102 (61,430 - 90,489) 2000 Modelled IHME
81,620 (66,961 - 98,563) 2001 Modelled IHME
90,648 (74,363 - 110,021) 2002 Modelled IHME
100,290 (82,029 - 122,581) 2003 Modelled IHME
108,581 (88,444 - 134,207) 2004 Modelled IHME
113,488 (92,321 - 140,087) 2005 Modelled IHME
115,766 (94,540 - 142,500) 2006 Modelled IHME
117,669 (96,022 - 143,790) 2007 Modelled IHME
119,364 (97,188 - 145,487) 2008 Modelled IHME
121,020 (98,704 - 147,033) 2009 Modelled IHME
122,810 (100,297 - 149,141) 2010 Modelled IHME
124,665 (102,004 - 150,757) 2011 Modelled IHME
126,477 (103,723 - 152,750) 2012 Modelled IHME
128,355 (105,134 - 155,180) 2013 Modelled IHME
130,407 (106,981 - 158,355) 2014 Modelled IHME
132,746 (108,300 - 162,502) 2015 Modelled IHME
136,213 (111,582 - 168,035) 2016 Modelled IHME
139,963 (114,136 - 174,415) 2017 Modelled IHME
142,898 (117,273 - 176,993) 2018 Modelled IHME
145,471 (119,006 - 178,412) 2019 Modelled IHME
108,000 (25,000 - 123,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.14 (4.84 - 10.30) 2019 Modelled IHME
7.03 (4.72 - 10.10) 2018 Modelled IHME
6.92 (4.70 - 9.91) 2017 Modelled IHME
6.83 (4.65 - 9.81) 2016 Modelled IHME
6.74 (4.65 - 9.75) 2015 Modelled IHME
6.64 (4.61 - 9.38) 2014 Modelled IHME
6.52 (4.52 - 9.03) 2013 Modelled IHME
6.41 (4.47 - 8.89) 2012 Modelled IHME
6.3 (4.39 - 8.61) 2011 Modelled IHME
6.19 (4.29 - 8.44) 2010 Modelled IHME
6.09 (4.24 - 8.16) 2009 Modelled IHME
6 (4.24 - 8.04) 2008 Modelled IHME
5.91 (4.21 - 7.93) 2007 Modelled IHME
5.83 (4.21 - 7.90) 2006 Modelled IHME
5.75 (4.18 - 7.70) 2005 Modelled IHME
5.67 (4.17 - 7.54) 2004 Modelled IHME
5.55 (4.06 - 7.26) 2003 Modelled IHME
5.42 (3.98 - 7.02) 2002 Modelled IHME
5.3 (3.91 - 6.83) 2001 Modelled IHME
5.22 (3.94 - 6.69) 2000 Modelled IHME
5.17 (3.96 - 6.52) 1999 Modelled IHME
5.11 (3.93 - 6.37) 1998 Modelled IHME
5.01 (3.85 - 6.31) 1997 Modelled IHME
4.89 (3.77 - 6.16) 1996 Modelled IHME
4.87 (3.78 - 6.06) 1995 Modelled IHME
4.78 (3.71 - 6.06) 1994 Modelled IHME
4.82 (3.69 - 6.15) 1993 Modelled IHME
4.78 (3.64 - 6.25) 1992 Modelled IHME
4.77 (3.58 - 6.30) 1991 Modelled IHME
4.71 (3.42 - 6.28) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
826 (560 - 1,196) 2019 Modelled IHME
808 (543 - 1,159) 2018 Modelled IHME
791 (537 - 1,132) 2017 Modelled IHME
775 (528 - 1,113) 2016 Modelled IHME
759 (524 - 1,098) 2015 Modelled IHME
742 (515 - 1,049) 2014 Modelled IHME
723 (501 - 1,001) 2013 Modelled IHME
705 (492 - 977) 2012 Modelled IHME
687 (479 - 939) 2011 Modelled IHME
670 (464 - 914) 2010 Modelled IHME
653 (456 - 876) 2009 Modelled IHME
638 (451 - 856) 2008 Modelled IHME
624 (445 - 837) 2007 Modelled IHME
610 (441 - 827) 2006 Modelled IHME
598 (434 - 799) 2005 Modelled IHME
584 (429 - 776) 2004 Modelled IHME
566 (414 - 740) 2003 Modelled IHME
547 (403 - 709) 2002 Modelled IHME
530 (392 - 683) 2001 Modelled IHME
517 (390 - 662) 2000 Modelled IHME
506 (388 - 639) 1999 Modelled IHME
494 (380 - 617) 1998 Modelled IHME
479 (368 - 603) 1997 Modelled IHME
461 (355 - 580) 1996 Modelled IHME
452 (351 - 563) 1995 Modelled IHME
437 (338 - 553) 1994 Modelled IHME
432 (330 - 552) 1993 Modelled IHME
421 (320 - 550) 1992 Modelled IHME
411 (309 - 543) 1991 Modelled IHME
397 (289 - 530) 1990 Modelled IHME
877 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
48 (38 - 58) 2019 Modelled IHME
48 (37 - 58) 2018 Modelled IHME
48 (37 - 57) 2017 Modelled IHME
48 (38 - 57) 2016 Modelled IHME
49 (38 - 58) 2015 Modelled IHME
49 (38 - 58) 2014 Modelled IHME
49 (38 - 58) 2013 Modelled IHME
49 (39 - 58) 2012 Modelled IHME
49 (39 - 58) 2011 Modelled IHME
49 (39 - 58) 2010 Modelled IHME
49 (39 - 58) 2009 Modelled IHME
49 (38 - 58) 2008 Modelled IHME
48 (38 - 58) 2007 Modelled IHME
48 (38 - 58) 2006 Modelled IHME
48 (38 - 57) 2005 Modelled IHME
48 (38 - 57) 2004 Modelled IHME
48 (38 - 57) 2003 Modelled IHME
48 (37 - 56) 2002 Modelled IHME
47 (37 - 56) 2001 Modelled IHME
47 (37 - 56) 2000 Modelled IHME
47 (37 - 56) 1999 Modelled IHME
47 (37 - 55) 1998 Modelled IHME
46 (36 - 55) 1997 Modelled IHME
46 (36 - 55) 1996 Modelled IHME
46 (35 - 55) 1995 Modelled IHME
46 (35 - 54) 1994 Modelled IHME
45 (35 - 54) 1993 Modelled IHME
45 (35 - 54) 1992 Modelled IHME
45 (34 - 54) 1991 Modelled IHME
45 (34 - 54) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2014 Survey/reported Ministere de la Sante Publique, 2014.
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
2006
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
211
2019
(143 - 313)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
826
2019
(560 - 1,196)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
74 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2014
(0 - 0)
Ministere de la Sante Publique, 2014.
Eligible for HBV generic medicines
Eligible for HCV generic medicines